Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/1995
12/12/1995US5475015 Benzimidazole derivatives, their preparation and pharmaceutical use
12/12/1995US5475007 Preventing convulsions
12/12/1995US5475004 Angiotensin II receptor antagonists for the treatment and prophylaxis of coronary heart disease
12/12/1995US5474996 Angiotension II inhibitors
12/12/1995US5474987 Methods of using low molecular weight heparins treatment of pathological processes
12/12/1995US5474978 Insulin analog formulations
12/12/1995US5474760 Method of inhibiting oxidants using alkylaryl polyether alcohol polymers
12/12/1995US5474759 Non-chlorofluorocarbon aerosol formulations
12/12/1995CA2070388C Antihypertensive compositions and use thereof
12/11/1995CA2151412A1 Modified guanidino and amidino thrombin inhibitors
12/11/1995CA2151113A1 Imidazolinyl tachykinin receptor antagonists
12/11/1995CA2150992A1 Cyclohexyl tachykinin receptor antagonists
12/09/1995CA2150960A1 Use of n-[[5-(naphthalen-1-yl)-1,3-dioxan-2-yl]alkyl] -acetamide derivatives for the preparation of medicinal products which are useful in the treatment of neurodegenerative disorders
12/08/1995CA2148977A1 Methods for the inhibition of platelet adherence and aggregation
12/07/1995WO1995032719A1 Use of oligonucleotide phosphorothioate for depleting complement and for reducing blood pressure
12/07/1995WO1995032715A1 Nitric oxide donor composition and method for treatment of anal disorders
12/07/1995CA2191192A1 Use of oligonucleotide phosphorothioate for depleting complement and for reducing blood pressure
12/06/1995EP0685491A2 Process for producing albumin preparation
12/06/1995EP0685490A1 Process for the purification of homogeneous platelet-derived endothelial cell growth factor from a platelet lysate
12/06/1995EP0685475A1 Amino-benzofuryl-and thienyl-derivatives
12/06/1995EP0685474A1 Oxalylamino-benzofuran- and benzothienyl-derivatives
12/06/1995EP0685466A1 3-Heteroaliphatyle-and 3-hetero-(aryle)-aliphatyle-2(1H)-quinolone derivatives
12/06/1995EP0684953A1 Adenosine kinase inhibitors comprising lyxofuranosyl derivatives
12/06/1995EP0684949A1 Chemical compounds
12/06/1995EP0684947A1 Amide compounds with pharmacological activity
12/06/1995EP0684945A1 Heterocyclic-substituted alkyl amide acat inhibitors
12/06/1995EP0684944A1 Coupling product obtained from hystamine and an amino acid
12/06/1995EP0684816A1 5-ht 2? receptor antagonist compositions useful in treating venous conditions
12/06/1995EP0588850B1 N-hydroxyurea derivatives which inhibit lipoxygenase
12/06/1995EP0445255B1 Treatment of conditions and disease
12/06/1995CN1112919A Pharmaceutical agents for the treatment of myocardial reperfusion injury and myocardial stunning
12/05/1995US5473054 IGF-1 analogs
12/05/1995US5472985 Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
12/05/1995US5472979 1,2,3,4-tetrahydronaphthalene compounds
12/05/1995US5472977 Administering 3,4-(diphenyl)chromans
12/05/1995US5472968 Spiro[cycloalkylbenzene-1,1'-(1',2',3',4'-tetrahydro-isoquinolines)] having neuroprotective properties
12/05/1995US5472961 Acetamides
12/05/1995US5472959 Hypotensive agents, congestive heart failure
12/05/1995US5472939 Method of treating complement mediated disorders
12/05/1995US5472873 Rhodotorula rubra useful in a process for the preparation of (ω-1)-hydroxyalkylxanthines
12/05/1995US5472730 γ-aminobutyric acid-enriched food material and method for producing γ-aminobutyric acid
12/03/1995CA2150645A1 3-heteroaliphatyl- and 3-hetero(aryl)aliphatyl-2(1h) -quinolone derivatives
12/02/1995CA2150612A1 Process for producing albumin preparation
12/01/1995CA2150301A1 Oxalylamino-benzofuran-and benzothienyl-derivatives
12/01/1995CA2150300A1 Amino-benzofuryl- and thienyl-derivatives
11/1995
11/30/1995WO1995032298A2 Safe vectors for gene therapy
11/30/1995WO1995032282A1 Interleukin-6 splice variant
11/30/1995WO1995032218A1 Neurotensin antagonist peptides
11/30/1995WO1995032217A1 Peptide antagonist intermediates of neurotensin
11/30/1995WO1995032205A1 Tricyclic dicarbonyl derivatives
11/30/1995WO1995032203A2 Use of tetrahydropteridine derivatives as no-synthase inhibitors
11/30/1995WO1995032198A1 Imidazole derivatives and processes for the preparation thereof
11/30/1995WO1995032197A1 Palladium catalyzed ring closure of triazolyl tryptamine
11/30/1995WO1995032196A1 Piperazine, piperidine and tetrahydropyridine derivatives of indol-3-ylalkyl as 5-ht1d-alpha agonists
11/30/1995WO1995032194A1 Synthesis of optically pure 4-alkenyl- or 4-alkanyl-2-hydroxytetronic acids
11/30/1995WO1995031996A1 Materials and methods for treatment of plaquing diseases
11/30/1995WO1995031987A1 Use of pteridine derivatives as no-synthase inhibitors
11/30/1995WO1995031965A1 Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods of use
11/30/1995DE4418097A1 Verwendung von Tetrahydropteridin-Derivaten als Hemmstoffe der NO-Synthase Using Tetrahydropteridin derivatives as inhibitors of NO synthase
11/30/1995DE4418096A1 Verwendung von Pteridin-Derivaten als Hemmstoffe der NO-Synthase The use of pteridine derivatives as inhibitors of NO synthase
11/30/1995CA2190501A1 Piperazine, piperidine and tetrahydropyridine derivatives of indol-3-ylalkyl as 5-ht1d-alpha agonists
11/30/1995CA2190468A1 Synthesis of optically pure 4-alkenyl- or 4-alkanyl-2-hydroxytetronic acids
11/30/1995CA2190247A1 Safe vectors for gene therapy
11/30/1995CA2189776A1 Tricyclic dicarbonyl derivatives
11/29/1995EP0684240A1 Hydroxamic acid derivatives with tricyclic substitution
11/29/1995EP0683782A1 Spiro (2h-1-benzopyran-2, 4' piperidine) class iii antiarrhythmics
11/29/1995EP0683781A1 Novel inhibitors of adenosine monophosphate deaminase
11/29/1995EP0683775A1 Heterocyclic 4-aminomethylpiperidine derivatives, their preparation and application in therapy
11/29/1995EP0683774A1 Hypolipidaemic compounds
11/29/1995EP0683672A1 Extract from flowers of salvia officinalis, process for its preparation and use thereof
11/29/1995CN1112560A Piperidine derivatives and anti-platelet agents containing the same
11/29/1995CN1112554A Derivative of 1-|2-(1H-indene-3-yl)ethyl¨-4-(naphthalene-1-yl)-piperazine and preparation and application of same
11/29/1995CN1112550A 4-amino-1-piperidylbenzoylguanidine
11/28/1995US5470872 Muscle relaxants
11/28/1995US5470871 Therapeutic compositions based on 1,2-dithiole-3-thione derivatives
11/28/1995US5470867 Imidazoles and their salts having antagonistic activity to angiotesin II recetors
11/28/1995US5470855 Certain heterocyclic thiazole derivatives and their therapeutic use
11/28/1995US5470852 Tetrahydroprotoberberine quaternary ammonium compounds useful in for treating arrhythmia
11/28/1995US5470849 Anticoagulants
11/28/1995CA1337659C Optical isomers of an imidazole derivative
11/28/1995CA1337655C 1,2,3,4-tetrahydro-6-substituted-4-aryl(or heterocyclo)-3-¬(substituted amino)carbonyl|-2-thioxo(or oxo)-5-pyrimidinecarboxylic acids and esters
11/28/1995CA1337654C Fused tricyclic lactams as antihypertensive agents
11/28/1995CA1337653C 2-hydroxy-3-phenoxypropyl-substituted piperazines and homopiperazines, the preparation and use thereof
11/23/1995WO1995031543A1 Dna encoding the beta subunit of a mammalian 'maxi-k' potassium channel
11/23/1995WO1995031541A2 Methods and compositions for treatment of restenosis and cancer using ribozymes
11/23/1995WO1995031539A1 Neurotransmitter transporter
11/23/1995WO1995031467A1 Monocyte chemotactic protein-4
11/23/1995WO1995031197A1 Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
11/23/1995CA2190513A1 Methods and compositions for treatment of restenosis and cancer using ribozymes
11/23/1995CA2189761A1 Dna encoding the beta subunit of a mammalian "maxi-k" potassium channel
11/23/1995CA2189528A1 Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
11/22/1995EP0683173A1 Cyclic adhesion inhibitors
11/22/1995EP0683172A1 11,21-Bisphenyl-19-norpregnane derivatives
11/22/1995EP0683167A1 Terazosin monohydrochloride and processes and intermediate for its production
11/22/1995EP0683166A1 3-Indolylpiperidines
11/22/1995EP0683159A1 Substituted furoxanes
11/22/1995EP0682880A2 R-aminobutyric acid-enriched food material and method for producing r-aminobutyric acid
11/22/1995EP0682526A1 PULMONARY ADMINISTRATION OF sCR1 AND OTHER COMPLEMENT INHIBITORY PROTEINS
11/22/1995EP0682520A1 Combination of a calcium channel blocker and an antioxydant for treating ischemic diseases
11/22/1995EP0682516A1 Therapeutic use of compounds having selective agonist-like activity on rxr retinoid receptors
1 ... 1417 1418 1419 1420 1421 1422 1423 1424 1425 1426 1427 1428 1429 1430 1431 1432 1433 1434 1435 1436 1437 ... 1595